Promoter holding
64.27%
AE
Advanced Enzyme Technologies Limited - Due diligence report
A 360° intelligence report on Advanced Enzyme: trust score, financial health, credit view, compliance, directors, growth and distress signal…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Advanced Enzyme — 360° Intelligence Report
Generated from MCA filings & public records82/100
Trust Score
Low Risk
Advanced Enzyme is assessed as Low Risk with a Trust Score of 82/100. Advanced Enzyme is an active public limited indian non-government company incorporated in 1989, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Advanced Enzyme Technologies Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
55/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A1).
Charges position: 2 open (30.00 cr) · 28 satisfied (218.50 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Citi Bank N.A. | 2 | 48.0 cr |
| Others | 4 | 48.0 cr |
| Kotak Mahindra Bank Limited | 1 | 48.0 cr |
| Dbs Bank Ltd | 1 | 48.0 cr |
| Hdfc Bank Limited | 2 | 48.0 cr |
| Union Bank Of India | 11 | 48.0 cr |
Compliance Score: 55/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BSE.
- Litigation present in 1 court forum(s).
- Delayed payments to MSME suppliers disclosed (16 disclosure(s)).
- 3 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VANDANA RAVINDRA TILAK | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BENI PRASAD RAUKA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJSHREE PATEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NITIN JAGANNATH DESHMUKH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VINODKUMAR JAJOO HIRALAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUNNY SHARMA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJAY PRAKASH BASANTANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RASIKA VASANT RATHI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VASANT RATHI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BENI PRASAD RAUKA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRAMOD KASAT | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MUKUND MADHUSUDAN KABRA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 12 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2020)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
3
Group entities
3
Capital events
18 allotment(s) · 0 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Advanced Enzyme Supplementary Technologies Corporation | Subsidiary Company | 74.00% |
| Advanced Enzymes (malaysia) Sdn. Bhd. | Subsidiary Company | 74.00% |
| Advanced Enzymes Europe B.v. | Subsidiary Company | 74.00% |
| Advanced Enzymes Usa | Subsidiary Company | 74.00% |
| Cal-india Foods International | Subsidiary Company | 74.00% |
| Dynamic Enzymes Inc. | Subsidiary Company | 74.00% |
| Enzyme Innovation Inc. | Subsidiary Company | 74.00% |
| Evoxx Technologies Gmbh | Subsidiary Company | 74.00% |
| Advanced Enzytech Solutions Limited | Subsidiary Company | 74.00% |
| Jc Biotech Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: BENI PRASAD RAUKA (CFO) · BENI PRASAD RAUKA (CFO) · MUKUND MADHUSUDAN KABRA (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 65 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 37+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (55/100).
2 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 13.62 Lakh.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment85/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 30.00 cr already registered.
- Compliance gaps should be priced into terms.
Investor view80/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Jul 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
03 Mar 2025
Charge satisfied
Dbs Bank Ltd.
01 Aug 2024
Charge satisfied
Axis Bank Limited
20 Apr 2024
Charge satisfied
Others
11 Aug 2023
Director ceased
VANDANA RAVINDRA TILAK
01 Jul 2023
Director appointed
VANDANA RAVINDRA TILAK (Director)
29 Mar 2023
Charge satisfied
Hdfc Bank Limited
13 Mar 2023
Charge satisfied
Others
30 Sep 2022
Securities allotted
4250 Equity Shares - 2.55 Lakh raised
19 Aug 2022
Director ceased
NITIN JAGANNATH DESHMUKH
21 Jul 2022
Securities allotted
11250 Equity Shares - 6.75 Lakh raised
01 Jul 2022
Director appointed
NITIN JAGANNATH DESHMUKH (Director)
29 Jun 2022
Charge created
Axis Bank Limited - 5.00 cr
20 May 2022
Securities allotted
5900 Equity Shares - 3.54 Lakh raised
10
Key Observations
Auto-generated from the data aboveRevenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
12 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 3 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of A1 from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 18 security allotment(s) - amounts available in the full report.
23 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Pj Margo | U24119KA1994PTC016163 | Indl. Area,Bangalore, Karnataka, India |
| Sapphire Lifesciences Private Limited | U24239MH1990PTC055572 | Palghar, Maharashtra, India |
| Synergy Air Products Private Limited | U40200PN2005PTC021168 | Pune - 412 208, Maharashtra, India |
| Bharat Carbonates Private Limited | U24321GJ1997PTC032820 | Surat, Gujarat, India |
| Walparnutritions | L24230GJ2020PLC118662 | Gandhinagar, Gujarat, India |
| Senores Pharmaceuticals | L24290GJ2017PLC100263 | Ahmedabad, Gujarat, India |
| Medcell Pharma Private Limited | U24230HR2022PTC106564 | Gurugram, Haryana, India |
| Axxelent Pharma Science Private Limited | U24110TN2019PTC131943 | Chennai, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Advanced Enzyme before audits and certifications: compliance score 55/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Advanced Enzyme: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Advanced Enzyme - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Advanced Enzyme pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Advanced Enzyme - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Advanced Enzyme an active company?
Advanced Enzyme has MCA status “Active” with a compliance score of 55/100 (Moderate).
Is Advanced Enzyme financially healthy?
Advanced Enzyme has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Advanced Enzyme?
Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Advanced Enzyme?
Promoters hold a minority stake - exact percentages are in the full report. 12 active director(s) are on record.
Does Advanced Enzyme have loans or charges against its assets?
2 open charge(s) are registered against its assets, and 28 earlier charge(s) stand satisfied.
Is Advanced Enzyme up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 55/100 (Moderate).
Is it risky to lend to Advanced Enzyme?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
